{"transactions":[{"id":2895,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2026-09-03T20:50:59.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":1131,"price":857.39,"value":969708.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026."}],"balance_after":12003,"source":{"system":"sec-edgar","filing":"0001663758-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1663758/000166375826000002/edgardoc.xml","form_type":"4"}},{"id":2894,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2026-09-03T20:50:59.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":1215,"price":850,"value":1032750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026."}],"balance_after":13134,"source":{"system":"sec-edgar","filing":"0001663758-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1663758/000166375826000002/edgardoc.xml","form_type":"4"}},{"id":973339,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2025-12-11T21:30:49.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1021,"price":701.51,"value":716241.71,"ownership":{"direct":true},"balance_after":14349,"source":{"system":"sec-edgar","filing":"0001663758-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000166375825000009/edgardoc.xml","form_type":"4"}},{"id":976910,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-09T21:10:59.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":12210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":12210,"derivative":{"exercise_price":726.71,"expiration_date":"2035-12-05","underlying":"Common Stock","underlying_shares":12210},"source":{"system":"sec-edgar","filing":"0001663758-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000166375825000007/edgardoc.xml","form_type":"4"}},{"id":976909,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:59.000Z","date":"2025-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1336,"price":712.94,"value":952487.84,"ownership":{"direct":true},"balance_after":15370,"source":{"system":"sec-edgar","filing":"0001663758-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000166375825000007/edgardoc.xml","form_type":"4"}},{"id":976908,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2025-12-09T21:10:59.000Z","date":"2025-12-05","kind":"grant","planned":false,"acquired":true,"shares":2476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029."}],"balance_after":16706,"source":{"system":"sec-edgar","filing":"0001663758-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000166375825000007/edgardoc.xml","form_type":"4"}},{"id":1327433,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-12-18T21:02:07.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":759,"price":730.81,"value":554684.79,"ownership":{"direct":true},"balance_after":14230,"source":{"system":"sec-edgar","filing":"0001883850-24-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000063/edgardoc.xml","form_type":"4"}},{"id":1338108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-12-10T21:03:00.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":8981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":8981,"derivative":{"exercise_price":771.64,"expiration_date":"2034-12-06","underlying":"Common Stock","underlying_shares":8981},"source":{"system":"sec-edgar","filing":"0001968202-24-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000136/edgardoc.xml","form_type":"4"}},{"id":1338107,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:00.000Z","date":"2024-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":274,"price":787,"value":215638.0,"ownership":{"direct":true},"balance_after":14989,"source":{"system":"sec-edgar","filing":"0001968202-24-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000136/edgardoc.xml","form_type":"4"}},{"id":1338106,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-12-10T21:03:00.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":2332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028."}],"balance_after":15263,"source":{"system":"sec-edgar","filing":"0001968202-24-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000136/edgardoc.xml","form_type":"4"}},{"id":1376392,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-11-05T21:23:04.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vested in four equal annual installments, commencing one year after the date of grant."}],"balance_after":6000,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001968202-24-000132","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000132/edgardoc.xml","form_type":"4"}},{"id":1376391,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-11-05T21:23:04.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":844.61,"value":844610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001968202-24-000132","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000132/edgardoc.xml","form_type":"4"}},{"id":1376390,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-11-05T21:23:04.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":381.4,"value":381400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":13931,"source":{"system":"sec-edgar","filing":"0001968202-24-000132","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000132/edgardoc.xml","form_type":"4"}},{"id":1393015,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-10-03T20:02:07.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001968202-24-000129","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000129/edgardoc.xml","form_type":"4"}},{"id":1393014,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-10-03T20:02:07.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":1054.06,"value":1054060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001968202-24-000129","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000129/edgardoc.xml","form_type":"4"}},{"id":1393013,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-10-03T20:02:07.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":381.4,"value":381400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":13931,"source":{"system":"sec-edgar","filing":"0001968202-24-000129","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000129/edgardoc.xml","form_type":"4"}},{"id":1414667,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-09-05T20:01:28.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":8000,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001968202-24-000125","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000125/edgardoc.xml","form_type":"4"}},{"id":1414666,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-09-05T20:01:28.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":1178.73,"value":1178730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001968202-24-000125","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000125/edgardoc.xml","form_type":"4"}},{"id":1414665,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-09-05T20:01:28.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":381.4,"value":381400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":13931,"source":{"system":"sec-edgar","filing":"0001968202-24-000125","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000125/edgardoc.xml","form_type":"4"}},{"id":1441594,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-08-05T20:04:55.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":1137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1137},"source":{"system":"sec-edgar","filing":"0001883850-24-000040","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000040/edgardoc.xml","form_type":"4"}},{"id":1441593,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-08-05T20:04:55.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":1137,"price":1060.86,"value":1206197.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001883850-24-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000040/edgardoc.xml","form_type":"4"}},{"id":1441592,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-08-05T20:04:55.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":1137,"price":372.46,"value":423487.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":14068,"source":{"system":"sec-edgar","filing":"0001883850-24-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000040/edgardoc.xml","form_type":"4"}},{"id":1464386,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-02T20:01:51.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":1137,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1137},"source":{"system":"sec-edgar","filing":"0001968202-24-000106","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000106/edgardoc.xml","form_type":"4"}},{"id":1464385,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-07-02T20:01:51.000Z","date":"2024-07-01","kind":"sale","planned":true,"acquired":false,"shares":1137,"price":1047.11,"value":1190564.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001968202-24-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000106/edgardoc.xml","form_type":"4"}},{"id":1464384,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-07-02T20:01:51.000Z","date":"2024-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1137,"price":372.46,"value":423487.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":14068,"source":{"system":"sec-edgar","filing":"0001968202-24-000106","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000106/edgardoc.xml","form_type":"4"}},{"id":1490923,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-05T20:07:01.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":false,"shares":1138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":2274,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1138},"source":{"system":"sec-edgar","filing":"0001968202-24-000100","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000100/edgardoc.xml","form_type":"4"}},{"id":1490922,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-06-05T20:07:01.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":1138,"price":980.16,"value":1115422.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001968202-24-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000100/edgardoc.xml","form_type":"4"}},{"id":1490921,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-06-05T20:07:01.000Z","date":"2024-06-03","kind":"exercise","planned":true,"acquired":true,"shares":1138,"price":372.46,"value":423859.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024."}],"balance_after":14069,"source":{"system":"sec-edgar","filing":"0001968202-24-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000100/edgardoc.xml","form_type":"4"}},{"id":1529374,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-05-03T20:02:19.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":889.41,"value":222352.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":12931,"source":{"system":"sec-edgar","filing":"0001883850-24-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000018/edgardoc.xml","form_type":"4"}},{"id":1551553,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-04-03T20:05:44.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":964.73,"value":241182.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":13181,"source":{"system":"sec-edgar","filing":"0001968202-24-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000089/edgardoc.xml","form_type":"4"}},{"id":1599803,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-03-05T21:01:35.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":358,"price":967.5,"value":346365.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":13431,"source":{"system":"sec-edgar","filing":"0001968202-24-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000083/edgardoc.xml","form_type":"4"}},{"id":1657471,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-02-06T21:08:02.000Z","date":"2024-02-05","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":934.71,"value":934710.0,"ownership":{"direct":true},"balance_after":13789,"source":{"system":"sec-edgar","filing":"0001968202-24-000052","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000052/edgardoc.xml","form_type":"4"}},{"id":1662923,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-02-02T21:02:55.000Z","date":"2024-02-01","kind":"sale","planned":true,"acquired":false,"shares":273,"price":945.61,"value":258151.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":14789,"source":{"system":"sec-edgar","filing":"0001968202-24-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000046/edgardoc.xml","form_type":"4"}},{"id":1689478,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2024-01-04T21:17:56.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":274,"price":873.91,"value":239451.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":15062,"source":{"system":"sec-edgar","filing":"0001883850-24-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385024000004/edgardoc.xml","form_type":"4"}},{"id":1711609,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-12-14T21:11:08.000Z","date":"2023-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":5105,"price":856.71,"value":4373504.55,"ownership":{"direct":true},"balance_after":15336,"source":{"system":"sec-edgar","filing":"0001968202-23-000056","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000056/edgardoc.xml","form_type":"4"}},{"id":1715281,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-12-12T21:04:30.000Z","date":"2023-12-08","kind":"grant","planned":true,"acquired":true,"shares":7649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7649,"derivative":{"exercise_price":843.79,"expiration_date":"2033-12-08","underlying":"Common Stock","underlying_shares":7649},"source":{"system":"sec-edgar","filing":"0001883850-23-000088","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000088/edgardoc.xml","form_type":"4"}},{"id":1715280,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-12-12T21:04:30.000Z","date":"2023-12-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":373,"price":844.09,"value":314845.57,"ownership":{"direct":true},"balance_after":20441,"source":{"system":"sec-edgar","filing":"0001883850-23-000088","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000088/edgardoc.xml","form_type":"4"}},{"id":1715279,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-12-12T21:04:30.000Z","date":"2023-12-11","kind":"sale","planned":true,"acquired":false,"shares":270,"price":838.44,"value":226378.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20814,"source":{"system":"sec-edgar","filing":"0001883850-23-000088","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000088/edgardoc.xml","form_type":"4"}},{"id":1715278,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-12-12T21:04:30.000Z","date":"2023-12-08","kind":"grant","planned":true,"acquired":true,"shares":2133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2025 and 50% on December 8, 2027."}],"balance_after":21084,"source":{"system":"sec-edgar","filing":"0001883850-23-000088","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000088/edgardoc.xml","form_type":"4"}},{"id":1715277,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-12-12T21:04:30.000Z","date":"2023-12-08","kind":"tax_withholding","planned":true,"acquired":false,"shares":852,"price":843.79,"value":718909.08,"ownership":{"direct":true},"balance_after":18951,"source":{"system":"sec-edgar","filing":"0001883850-23-000088","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000088/edgardoc.xml","form_type":"4"}},{"id":1751831,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-11-02T20:03:22.000Z","date":"2023-11-01","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":9000,"derivative":{"exercise_price":381.4,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001883850-23-000079","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000079/edgardoc.xml","form_type":"4"}},{"id":1751830,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-11-02T20:03:22.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":783.91,"value":783910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":19803,"source":{"system":"sec-edgar","filing":"0001883850-23-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000079/edgardoc.xml","form_type":"4"}},{"id":1751829,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-11-02T20:03:22.000Z","date":"2023-11-01","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":381.4,"value":381400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20803,"source":{"system":"sec-edgar","filing":"0001883850-23-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000079/edgardoc.xml","form_type":"4"}},{"id":1769148,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-10-03T20:04:14.000Z","date":"2023-10-02","kind":"exercise","planned":true,"acquired":false,"shares":1038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":3412,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1038},"source":{"system":"sec-edgar","filing":"0001968202-23-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000035/edgardoc.xml","form_type":"4"}},{"id":1769147,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-10-03T20:04:14.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":1038,"price":827,"value":858426.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":19803,"source":{"system":"sec-edgar","filing":"0001968202-23-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000035/edgardoc.xml","form_type":"4"}},{"id":1769146,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-10-03T20:04:14.000Z","date":"2023-10-02","kind":"exercise","planned":true,"acquired":true,"shares":1038,"price":372.46,"value":386613.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20841,"source":{"system":"sec-edgar","filing":"0001968202-23-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000035/edgardoc.xml","form_type":"4"}},{"id":1788092,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-09-06T20:03:25.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":834.55,"value":208637.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":19803,"source":{"system":"sec-edgar","filing":"0001968202-23-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000033/edgardoc.xml","form_type":"4"}},{"id":1817081,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-08-03T20:02:20.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":744.66,"value":186165.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20053,"source":{"system":"sec-edgar","filing":"0001968202-23-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000019/edgardoc.xml","form_type":"4"}},{"id":1834582,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-07-06T20:02:23.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":250,"price":710.09,"value":177522.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20303,"source":{"system":"sec-edgar","filing":"0001968202-23-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000017/edgardoc.xml","form_type":"4"}},{"id":1870989,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-06-02T20:12:43.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":736,"value":184000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023."}],"balance_after":20553,"source":{"system":"sec-edgar","filing":"0001883850-23-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000072/edgardoc.xml","form_type":"4"}},{"id":1925955,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-04-05T20:00:59.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 7, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":4450,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001968202-23-000005","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000005/edgardoc.xml","form_type":"4"}},{"id":1925954,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-04-05T20:00:59.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":818.8,"value":900680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 7, 2022."}],"balance_after":20803,"source":{"system":"sec-edgar","filing":"0001968202-23-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000005/edgardoc.xml","form_type":"4"}},{"id":1925953,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-04-05T20:00:59.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 7, 2022."}],"balance_after":21903,"source":{"system":"sec-edgar","filing":"0001968202-23-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000005/edgardoc.xml","form_type":"4"}},{"id":1976471,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-03-03T21:03:08.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":5550,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-23-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000053/edgardoc.xml","form_type":"4"}},{"id":1976470,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-03-03T21:03:08.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1100,"price":759.89,"value":835879.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20803,"source":{"system":"sec-edgar","filing":"0001883850-23-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000053/edgardoc.xml","form_type":"4"}},{"id":1976469,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-03-03T21:03:08.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":21903,"source":{"system":"sec-edgar","filing":"0001883850-23-000053","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000053/edgardoc.xml","form_type":"4"}},{"id":2017944,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-02-14T21:24:46.000Z","date":"2023-02-12","kind":"tax_withholding","acquired":false,"shares":1276,"price":751.78,"value":959271.28,"ownership":{"direct":true},"balance_after":20803,"source":{"system":"sec-edgar","filing":"0001883850-23-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000048/edgardoc.xml","form_type":"4"}},{"id":2027182,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-08T21:14:27.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":6650,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001883850-23-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000043/edgardoc.xml","form_type":"4"}},{"id":2027181,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-02-08T21:14:27.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":1000,"price":769.04,"value":769040.0,"ownership":{"direct":true},"balance_after":22079,"source":{"system":"sec-edgar","filing":"0001883850-23-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000043/edgardoc.xml","form_type":"4"}},{"id":2027180,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-02-08T21:14:27.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":1000,"price":372.46,"value":372460.0,"ownership":{"direct":true},"balance_after":23079,"source":{"system":"sec-edgar","filing":"0001883850-23-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000043/edgardoc.xml","form_type":"4"}},{"id":2034185,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-03T21:13:48.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":7650,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-23-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000029/edgardoc.xml","form_type":"4"}},{"id":2034184,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-02-03T21:13:48.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":1100,"price":752.19,"value":827409.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22079,"source":{"system":"sec-edgar","filing":"0001883850-23-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000029/edgardoc.xml","form_type":"4"}},{"id":2034183,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-02-03T21:13:48.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":23179,"source":{"system":"sec-edgar","filing":"0001883850-23-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000029/edgardoc.xml","form_type":"4"}},{"id":2064250,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:22:31.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":8750,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-23-000021","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000021/edgardoc.xml","form_type":"4"}},{"id":2064249,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-01-05T21:22:31.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1100,"price":721.86,"value":794046.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22079,"source":{"system":"sec-edgar","filing":"0001883850-23-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000021/edgardoc.xml","form_type":"4"}},{"id":2064248,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2023-01-05T21:22:31.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":23179,"source":{"system":"sec-edgar","filing":"0001883850-23-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000021/edgardoc.xml","form_type":"4"}},{"id":2080314,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-20T21:07:56.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":10971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10971,"derivative":{"exercise_price":726.53,"expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":10971},"source":{"system":"sec-edgar","filing":"0001883850-22-000134","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000134/edgardoc.xml","form_type":"4"}},{"id":2080313,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-12-20T21:07:56.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":2973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026."}],"balance_after":22079,"source":{"system":"sec-edgar","filing":"0001883850-22-000134","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000134/edgardoc.xml","form_type":"4"}},{"id":2088773,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-12-13T21:13:26.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":264,"price":730.17,"value":192764.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19106,"source":{"system":"sec-edgar","filing":"0001883850-22-000123","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000123/edgardoc.xml","form_type":"4"}},{"id":2088772,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-12-13T21:13:26.000Z","date":"2022-12-09","kind":"tax_withholding","acquired":false,"shares":274,"price":753.28,"value":206398.72,"ownership":{"direct":true},"balance_after":19370,"source":{"system":"sec-edgar","filing":"0001883850-22-000123","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000123/edgardoc.xml","form_type":"4"}},{"id":2099121,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-02T21:06:49.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":9850,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000103","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000103/edgardoc.xml","form_type":"4"}},{"id":2099120,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-12-02T21:06:49.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":1100,"price":756.19,"value":831809.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000103/edgardoc.xml","form_type":"4"}},{"id":2099119,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-12-02T21:06:49.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000103","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000103/edgardoc.xml","form_type":"4"}},{"id":2123800,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-07T21:05:05.000Z","date":"2022-11-04","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":10950,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001883850-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000090/edgardoc.xml","form_type":"4"}},{"id":2123799,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-11-07T21:05:05.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":1000,"price":727.82,"value":727820.0,"ownership":{"direct":true},"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000090/edgardoc.xml","form_type":"4"}},{"id":2123798,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-11-07T21:05:05.000Z","date":"2022-11-04","kind":"exercise","acquired":true,"shares":1000,"price":372.46,"value":372460.0,"ownership":{"direct":true},"balance_after":20644,"source":{"system":"sec-edgar","filing":"0001883850-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000090/edgardoc.xml","form_type":"4"}},{"id":2127719,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-02T20:03:48.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":11950,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000085","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000085/edgardoc.xml","form_type":"4"}},{"id":2127718,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-11-02T20:03:48.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1100,"price":750,"value":825000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000085/edgardoc.xml","form_type":"4"}},{"id":2127717,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-11-02T20:03:48.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":1100,"price":372.46,"value":409706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000085/edgardoc.xml","form_type":"4"}},{"id":2142989,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":13050,"derivative":{"exercise_price":372.46,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2142988,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2142987,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":500,"price":705.39,"value":352695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2142986,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":500,"price":342.93,"value":171465.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20144,"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2142985,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":600,"price":705.39,"value":423234.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2142984,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-10-05T20:11:13.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":600,"price":372.46,"value":223476.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20244,"source":{"system":"sec-edgar","filing":"0001883850-22-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000078/edgardoc.xml","form_type":"4"}},{"id":2168292,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-02T20:07:29.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":500,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000060/edgardoc.xml","form_type":"4"}},{"id":2168291,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-09-02T20:07:29.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":1100,"price":577.62,"value":635382.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000060/edgardoc.xml","form_type":"4"}},{"id":2168290,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-09-02T20:07:29.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":1100,"price":342.93,"value":377223.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000060/edgardoc.xml","form_type":"4"}},{"id":2198283,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-02T20:28:42.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":1600,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000050/edgardoc.xml","form_type":"4"}},{"id":2198282,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-08-02T20:28:42.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":1100,"price":581.53,"value":639683.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000050/edgardoc.xml","form_type":"4"}},{"id":2198281,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-08-02T20:28:42.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":1100,"price":342.93,"value":377223.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000050/edgardoc.xml","form_type":"4"}},{"id":2215832,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-07-05T20:03:57.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":2700,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000048","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000048/edgardoc.xml","form_type":"4"}},{"id":2215831,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-07-05T20:03:57.000Z","date":"2022-07-01","kind":"sale","acquired":false,"shares":1100,"price":587.76,"value":646536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000048/edgardoc.xml","form_type":"4"}},{"id":2215830,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-07-05T20:03:57.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":1100,"price":342.93,"value":377223.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000048","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000048/edgardoc.xml","form_type":"4"}},{"id":2246084,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-03T20:00:47.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":3800,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001708138-22-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000042/edgardoc.xml","form_type":"4"}},{"id":2246083,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-06-03T20:00:47.000Z","date":"2022-06-01","kind":"sale","acquired":false,"shares":1100,"price":669.51,"value":736461.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001708138-22-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000042/edgardoc.xml","form_type":"4"}},{"id":2246082,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-06-03T20:00:47.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":1100,"price":342.93,"value":377223.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001708138-22-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000042/edgardoc.xml","form_type":"4"}},{"id":2285274,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-03T21:09:20.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":4900,"derivative":{"exercise_price":342.93,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001883850-22-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000043/edgardoc.xml","form_type":"4"}},{"id":2285273,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-05-03T21:09:20.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":1100,"price":656.97,"value":722667.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":19644,"source":{"system":"sec-edgar","filing":"0001883850-22-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000043/edgardoc.xml","form_type":"4"}},{"id":2285272,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":2036,"kind":"person","name":"McCourt Marion","position":1,"cik":"0001663758","reported_name":"McCourt Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2022-05-03T21:09:20.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":1100,"price":342.93,"value":377223.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001883850-22-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000043/edgardoc.xml","form_type":"4"}}],"next_cursor":"2022-05-03T21:09:20.000000Z,2285272"}